Congress Passes Bills Making Major Investments in Alzheimer’s
March 23, 2024 10:15 ET | UsAgainstAlzheimer's
Congress passes major investments in the fight against Alzheimer’s.
FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’s
March 08, 2024 07:55 ET | UsAgainstAlzheimer's
WASHINGTON, March 08, 2024 (GLOBE NEWSWIRE) -- The maker of donanemab, Eli Lilly, announced today that the Food and Drug Administration (FDA) will convene an advisory committee to consider the...